Abstract
Signaling mediates cellular responses to extracellular stimuli. The c-Jun NH2-terminal kinase (JNK) pathway exemplifies one subgroup of the mitogen-activated protein (MAP) kinases, which, besides having established functions in stress response, also contribute to development by an unknown mechanism1,2,3,4. We show by genome-wide location analysis that JNK binds to a large set of active promoters during the differentiation of stem cells into neurons. JNK-bound promoters are enriched with binding motifs for the transcription factor NF-Y but not for AP-1. NF-Y occupies these predicted sites, and overexpression of dominant-negative NF-YA reduces the JNK presence on chromatin. We find that histone H3 Ser10 (H3S10) is a substrate for JNK, and JNK-bound promoters are enriched for H3S10 phosphorylation. Inhibition of JNK signaling in post-mitotic neurons reduces phosphorylation at H3S10 and the expression of target genes. These results establish MAP kinase binding and function on chromatin at a novel class of target genes during stem cell differentiation.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A multi-omics integrative analysis based on CRISPR screens re-defines the pluripotency regulatory network in ESCs
Communications Biology Open Access 14 April 2023
-
IRE1α RIDD activity induced under ER stress drives neuronal death by the degradation of 14-3-3 θ mRNA in cortical neurons during glucose deprivation
Cell Death Discovery Open Access 03 June 2021
-
Gene expression profiling in neuronal cells identifies a different type of transcriptome modulated by NF-Y
Scientific Reports Open Access 10 December 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout





Accession codes
References
Wagner, E.F. & Nebreda, A.R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9, 537–549 (2009).
Karin, M. & Gallagher, E. From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life 57, 283–295 (2005).
Weston, C.R. & Davis, R.J. The JNK signal transduction pathway. Curr. Opin. Cell Biol. 19, 142–149 (2007).
Bogoyevitch, M.A. & Kobe, B. Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases. Microbiol. Mol. Biol. Rev. 70, 1061–1095 (2006).
Pearson, G. et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22, 153–183 (2001).
Gehani, S.S. et al. Polycomb group protein displacement and gene activation through MSK-dependent H3K27me3S28 phosphorylation. Mol. Cell 39, 886–900 (2010).
Lawrence, M.C. et al. The roles of MAPKs in disease. Cell Res. 18, 436–442 (2008).
Pokholok, D.K., Zeitlinger, J., Hannett, N.M., Reynolds, D.B. & Young, R.A. Activated signal transduction kinases frequently occupy target genes. Science 313, 533–536 (2006).
Hu, S. et al. Profiling the human protein-DNA interactome reveals ERK2 as a transcriptional repressor of interferon signaling. Cell 139, 610–622 (2009).
Bungard, D. et al. Signaling kinase AMPK activates stress-promoted transcription via histone H2B phosphorylation. Science 329, 1201–1205 (2010).
Simone, C. et al. p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci. Nat. Genet. 36, 738–743 (2004).
Binétruy, B., Heasley, L., Bost, F., Caron, L. & Aouadi, M. Concise review: regulation of embryonic stem cell lineage commitment by mitogen-activated protein kinases. Stem Cells 25, 1090–1095 (2007).
Amura, C.R., Marek, L., Winn, R.A. & Heasley, L.E. Inhibited neurogenesis in JNK1-deficient embryonic stem cells. Mol. Cell. Biol. 25, 10791–10802 (2005).
Xu, P. et al. In vitro development of mouse embryonic stem cells lacking JNK/stress-activated protein kinase–associated protein 1 (JSAP1) scaffold protein revealed its requirement during early embryonic neurogenesis. J. Biol. Chem. 278, 48422–48433 (2003).
Plachta, N., Bibel, M., Tucker, K.L. & Barde, Y.A. Developmental potential of defined neural progenitors derived from mouse embryonic stem cells. Development 131, 5449–5456 (2004).
Bibel, M., Richter, J., Lacroix, E. & Barde, Y.A. Generation of a defined and uniform population of CNS progenitors and neurons from mouse embryonic stem cells. Nat. Protoc. 2, 1034–1043 (2007).
Bibel, M. et al. Differentiation of mouse embryonic stem cells into a defined neuronal lineage. Nat. Neurosci. 7, 1003–1009 (2004).
Raman, M., Chen, W. & Cobb, M.H. Differential regulation and properties of MAPKs. Oncogene 26, 3100–3112 (2007).
Aplin, A.E., Hogan, B.P., Tomeu, J. & Juliano, R.L. Cell adhesion differentially regulates the nucleocytoplasmic distribution of active MAP kinases. J. Cell Sci. 115, 2781–2790 (2002).
Weston, C.R. & Davis, R.J. The JNK signal transduction pathway. Curr. Opin. Genet. Dev. 12, 14–21 (2002).
Bailey, T.L., Williams, N., Misleh, C. & Li, W.W. MEME: discovering and analyzing DNA and protein sequence motifs. Nucleic Acids Res. 34, W369–W373 (2006).
Shaulian, E. AP-1—the Jun proteins: oncogenes or tumor suppressors in disguise? Cell. Signal. 22, 894–899 (2010).
Dolfini, D., Zambelli, F., Pavesi, G. & Mantovani, R. A perspective of promoter architecture from the CCAAT box. Cell Cycle 8, 4127–4137 (2009).
Mantovani, R. et al. Dominant-negative analogs of NF-YA. J. Biol. Chem. 269, 20340–20346 (1994).
Bennett, B.L. et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 98, 13681–13686 (2001).
Baek, S.H. When signaling kinases meet histones and histone modifiers in the nucleus. Mol. Cell 42, 274–284 (2011).
Yoshioka, Y., Suyari, O. & Yamaguchi, M. Transcription factor NF-Y is involved in regulation of the JNK pathway during Drosophila thorax development. Genes Cells 13, 117–130 (2008).
Wood, J.L. & Russo, A.F. Autoregulation of cell-specific MAP kinase control of the tryptophan hydroxylase promoter. J. Biol. Chem. 276, 21262–21271 (2001).
Alabert, C. et al. Cell type-dependent control of NF-Y activity by TGF-β. Oncogene 25, 3387–3396 (2006).
Lecona, E. et al. Upregulation of annexin A1 expression by butyrate in human colon adenocarcinoma cells: role of p53, NF-Y, and p38 mitogen-activated protein kinase. Mol. Cell. Biol. 28, 4665–4674 (2008).
Rosso, S.B., Sussman, D., Wynshaw-Boris, A. & Salinas, P.C. Wnt signaling through Dishevelled, Rac and JNK regulates dendritic development. Nat. Neurosci. 8, 34–42 (2005).
Oliva, A.A. Jr. Atkins, C.M., Copenagle, L. & Banker, G.A. Activated c-Jun N-terminal kinase is required for axon formation. J. Neurosci. 26, 9462–9470 (2006).
Dawson, M.A. et al. JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin. Nature 461, 819–822 (2009).
Edmunds, J.W. & Mahadevan, L.C. MAP kinases as structural adaptors and enzymatic activators in transcription complexes. J. Cell Sci. 117, 3715–3723 (2004).
Zhang, W. et al. The JIL-1 histone H3S10 kinase regulates dimethyl H3K9 modifications and heterochromatic spreading in Drosophila. Development 133, 229–235 (2006).
Prigent, C. & Dimitrov, S. Phosphorylation of serine 10 in histone H3, what for? J. Cell Sci. 116, 3677–3685 (2003).
Nowak, S.J. & Corces, V.G. Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet. 20, 214–220 (2004).
Fischle, W. et al. Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation. Nature 438, 1116–1122 (2005).
Anest, V. et al. A nucleosomal function for IκB kinase-α in NF-κB–dependent gene expression. Nature 423, 659–663 (2003).
Cerutti, H. & Casas-Mollano, J.A. Histone H3 phosphorylation: universal code or lineage specific dialects? Epigenetics 4, 71–75 (2009).
Dyson, M.H. et al. MAP kinase–mediated phosphorylation of distinct pools of histone H3 at S10 or S28 via mitogen- and stress-activated kinase 1/2. J. Cell Sci. 118, 2247–2259 (2005).
Pérez-Cadahía, B., Drobic, B. & Davie, J.R. H3 phosphorylation: dual role in mitosis and interphase. Biochem. Cell Biol. 87, 695–709 (2009).
Sassone-Corsi, P. et al. Requirement of Rsk-2 for epidermal growth factor–activated phosphorylation of histone H3. Science 285, 886–891 (1999).
Yamamoto, Y., Verma, U.N., Prajapati, S., Kwak, Y.T. & Gaynor, R.B. Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression. Nature 423, 655–659 (2003).
Zippo, A., De Robertis, A., Serafini, R. & Oliviero, S. PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation. Nat. Cell Biol. 9, 932–944 (2007).
Mohn, F. et al. Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol. Cell 30, 755–766 (2008).
Glatter, T., Wepf, A., Aebersold, R. & Gstaiger, M. An integrated workflow for charting the human interaction proteome: insights into the PP2A system. Mol. Syst. Biol. 5, 237 (2009).
Langmead, B., Trapnell, C., Pop, M. & Salzberg, S.L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).
Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).
Bailey, T.L. & Elkan, C. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc. Int. Conf. Intell. Syst. Mol. Biol. 2, 28–36 (1994).
Bryne, J.C. et al. JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update. Nucleic Acids Res. 36, D102–D106 (2008).
Bailey, T.L. & Gribskov, M. Combining evidence using p-values: application to sequence homology searches. Bioinformatics 14, 48–54 (1998).
Gentleman, R.C. et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80 (2004).
Carvalho, B.S. & Irizarry, R.A. A framework for oligonucleotide microarray preprocessing. Bioinformatics 26, 2363–2367 (2010).
Acknowledgements
We thank L. Hoerner, M. Seimiya and I. Nissen for technical assistance, N. Tiwari for help with reagents and critical suggestions, G. Christofori, M. Bentires-Alj and members of the Schübeler laboratory for comments to the manuscript, R. Davis (University of Massachusetts Medical School, Worcester, Massachusetts, USA) for providing wild-type NIH3T3 cells and those lacking JNK1 and JNK2, and R. Mantovani (University of Milan, Milan, Italy) for the wild-type and dominant-negative NF-Y constructs. We thank the facilities at the Friedrich Miescher Institute, especially T. Roloff. Illumina sequencing was carried out at the Quantitative Genomics Facility of the Department of Biosystems Science and Engineering (D-BSSE), ETH Zurich. V.K.T. is supported by a Marie Curie International Incoming fellowship and an EMBO long-term postdoctoral fellowship. Research in the laboratory of R.P. is supported by the Deutsche Forschungsgemeinschaft (DFG), the European Union Epigenome Network of Excellence (EU-NoE) Epigenesys, Novartis and the ETH Zürich. Research in the laboratory of D.S. is supported by the Novartis Research Foundation, the European Union ((EU-NoE) Epigenesys, Blueprint)), the European Research Council (ERC-204264) and SystemsX.ch (Cell Plasticity).
Author information
Authors and Affiliations
Contributions
V.K.T. initiated and designed the study, performed experiments, analyzed data and wrote the manuscript. M.B.S. designed and performed the computational analysis and wrote the manuscript. C.W. performed experiments and analyzed data. R.P. provided input during the study and comments on the manuscript. C.B. initiated the study, performed experiments, analyzed data and wrote the manuscript. D.S. designed the study, analyzed data and wrote the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–10. (PDF 6847 kb)
Rights and permissions
About this article
Cite this article
Tiwari, V., Stadler, M., Wirbelauer, C. et al. A chromatin-modifying function of JNK during stem cell differentiation. Nat Genet 44, 94–100 (2012). https://doi.org/10.1038/ng.1036
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.1036
This article is cited by
-
A multi-omics integrative analysis based on CRISPR screens re-defines the pluripotency regulatory network in ESCs
Communications Biology (2023)
-
IRE1α RIDD activity induced under ER stress drives neuronal death by the degradation of 14-3-3 θ mRNA in cortical neurons during glucose deprivation
Cell Death Discovery (2021)
-
PPM1F in Dentate Gyrus Modulates Anxiety-Related Behaviors by Regulating BDNF Expression via AKT/JNK/p-H3S10 Pathway
Molecular Neurobiology (2021)
-
Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy
Clinical Epigenetics (2020)
-
Gene expression profiling in neuronal cells identifies a different type of transcriptome modulated by NF-Y
Scientific Reports (2020)